<tt>
<br>
&lt;!DOCTYPE&nbsp;HTML&nbsp;PUBLIC&nbsp;&quot;-//W3C//DTD&nbsp;HTML&nbsp;4.0&nbsp;Transitional//EN&quot;&gt;<br>
&lt;HTML&gt;&lt;HEAD&gt;<br>
&lt;META&nbsp;http-equiv=Content-Type&nbsp;content=&quot;text/html;&nbsp;charset=windows-1251&quot;&gt;<br>
&lt;META&nbsp;content=&quot;MSHTML&nbsp;6.00.2900.2180&quot;&nbsp;name=GENERATOR&gt;<br>
&lt;STYLE&gt;&lt;/STYLE&gt;<br>
&lt;/HEAD&gt;<br>
&lt;BODY&nbsp;bgColor=#ffffff&gt;<br>
&lt;DIV&gt;&lt;FONT&nbsp;face=Arial&nbsp;size=2&gt;The&nbsp;Senate&nbsp;action&nbsp;followed&nbsp;incremental&nbsp;changes&nbsp;at&nbsp;earlier&nbsp;committee&nbsp;meetings&lt;BR&gt;On&nbsp;Thursday&nbsp;evening,&nbsp;the&nbsp;Senate&nbsp;Judiciary&nbsp;Committee&nbsp;approved&nbsp;by&nbsp;a&nbsp;13-5&nbsp;vote&lt;BR&gt;&nbsp;amendments.&nbsp;Those&nbsp;inconsistencies&nbsp;will&nbsp;have&nbsp;to&nbsp;be&nbsp;reconciled&nbsp;if&nbsp;the&nbsp;full&nbsp;&lt;BR&gt;Patrick&nbsp;Leahy&nbsp;(D-Vt.),&nbsp;who&nbsp;co-sponsored&nbsp;the&nbsp;bill&nbsp;with&nbsp;Sen.&nbsp;Orrin&nbsp;Hatch&nbsp;(R-Utah),&lt;BR&gt;&nbsp;and&nbsp;arrived&nbsp;just&nbsp;one&nbsp;day&nbsp;after&nbsp;a&nbsp;similar&nbsp;bill&nbsp;cleared&nbsp;the&nbsp;House&nbsp;Judiciary&nbsp;&lt;BR&gt;Arguments&nbsp;for&nbsp;and&nbsp;against&nbsp;whether&nbsp;a&nbsp;single,&nbsp;unified&nbsp;patent&nbsp;bill&nbsp;will&nbsp;&lt;BR&gt;<br>
&lt;/FONT&gt;&lt;/DIV&gt;<br>
&lt;DIV&gt;&lt;a&nbsp;href=&quot;http://closewhy.cn&quot;&gt;&lt;IMG&nbsp;alt=&quot;&quot;&nbsp;hspace=0&nbsp;<br>
src=&quot;cid:001201c8096a$c4c75400$0121ee04@TOTO&quot;&nbsp;align=baseline&nbsp;border=0&gt;&lt;/a&gt;&lt;/DIV&gt;<br>
&lt;DIV&gt;&lt;FONT&nbsp;face=Arial&nbsp;size=2&gt;Procter&nbsp;&amp;&nbsp;Gamble),&nbsp;pharmaceutical&nbsp;makers,&nbsp;biotechnology&nbsp;and&nbsp;nanotechnology&nbsp;companies,&lt;BR&gt;actually&nbsp;make&nbsp;it&nbsp;to&nbsp;the&nbsp;president's&nbsp;desk&nbsp;this&nbsp;time&nbsp;around&nbsp;still&nbsp;remains&nbsp;to&nbsp;&lt;BR&gt;Both&nbsp;measures&nbsp;that&nbsp;passed&nbsp;this&nbsp;week&nbsp;share&nbsp;a&nbsp;number&nbsp;of&nbsp;core&nbsp;components,&lt;BR&gt;The&nbsp;bills&nbsp;were&nbsp;identical&nbsp;when&nbsp;they&nbsp;were&nbsp;unveiled&nbsp;with&nbsp;some&nbsp;fanfare&nbsp;at&nbsp;a&nbsp;press&nbsp;&lt;BR&gt;&nbsp;amendments.&nbsp;Those&nbsp;inconsistencies&nbsp;will&nbsp;have&nbsp;to&nbsp;be&nbsp;reconciled&nbsp;if&nbsp;the&nbsp;full&nbsp;&lt;BR&gt;like&nbsp;Qualcomm&nbsp;that&nbsp;rely&nbsp;heavily&nbsp;on&nbsp;licensing&nbsp;their&nbsp;patents.&lt;BR&gt;Both&nbsp;measures&nbsp;that&nbsp;passed&nbsp;this&nbsp;week&nbsp;share&nbsp;a&nbsp;number&nbsp;of&nbsp;core&nbsp;components,&lt;BR&gt;attempt&nbsp;at&nbsp;such&nbsp;massive&nbsp;overhauls&nbsp;sputtered&nbsp;and&nbsp;ultimately&nbsp;died&nbsp;over&nbsp;intense&nbsp;&lt;BR&gt;&nbsp;said&nbsp;in&nbsp;a&nbsp;statement&nbsp;after&nbsp;the&nbsp;vote.&lt;BR&gt;The&nbsp;bills&nbsp;were&nbsp;identical&nbsp;when&nbsp;they&nbsp;were&nbsp;unveiled&nbsp;with&nbsp;some&nbsp;fanfare&nbsp;at&nbsp;a&nbsp;press&nbsp;&lt;BR&gt;&nbsp;said&nbsp;of&nbsp;the&nbsp;Senate&nbsp;bill's&nbsp;approval.&nbsp;The&nbsp;group,&nbsp;whose&nbsp;members&nbsp;include&nbsp;Qualcomm,&lt;BR&gt;<br>
&lt;/FONT&gt;&lt;/DIV&gt;<br>
&lt;/BODY&gt;&lt;/HTML&gt;<br>

</tt>
